Research Paper Volume 15, Issue 18 pp 9695—9717

Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma


Figure 7. Drug sensitivity analysis in patients with RCC based on a risk model. (A) Differential expression analysis of seven CRSGs between high- and low-risk group. (B) Correlation analysis for the four DECRLs with seven CRSGs. (C) Correlation analysis for the risk model with seven CRSGs. (D) Differential analysis of four kinds of drug sensitivity. (E) Correlation analysis for those four drugs with the risk score. *p < 0.05. **p < 0.01. ***p < 0.001.